- Waldenström macroglobulinemia presenting with neurological symptoms after chemotherapy
-
Shaikh MS, Moiz B
- KMID: 2172737
- Blood Res.
- 2016 Mar;51(1):6-6.
- doi: 10.5045/br.2016.51.1.6
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Platelet-rich plasma: a healing virtuoso
-
Jain NK, Gulati M
- KMID: 2172736
- Blood Res.
- 2016 Mar;51(1):3-5.
- doi: 10.5045/br.2016.51.1.3
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
-
Palombi M, Scaramucci L, Giovannini M, Trawinska , Niscola P, de Fabritiis P
- KMID: 2172749
- Blood Res.
- 2016 Mar;51(1):66-66.
- doi: 10.5045/br.2016.51.1.66
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Application of next generation sequencing in the diagnosis and management of mast cell leukemia
-
Kim J
- KMID: 2172735
- Blood Res.
- 2016 Mar;51(1):1-2.
- doi: 10.5045/br.2016.51.1.1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Combined factor V and VIII deficiency in a young woman with abundant bleeding after tooth extraction
-
Ates I, Kaplan M, Tokgoz G, Ceran F, Akalın S, Ozet G
- KMID: 2172750
- Blood Res.
- 2016 Mar;51(1):67-68.
- doi: 10.5045/br.2016.51.1.67
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Extranasal natural killer/T-cell lymphoma initially presenting as myelofibrosis
-
Jang W, Kim M
- KMID: 2172738
- Blood Res.
- 2016 Mar;51(1):7-7.
- doi: 10.5045/br.2016.51.1.7
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Oligosecretory multiple myeloma: a case report
-
Khurana U, Joshi D, Santoshi J, Sharma T, Kapoor N
- KMID: 2172748
- Blood Res.
- 2016 Mar;51(1):63-65.
- doi: 10.5045/br.2016.51.1.63
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A case of Pneumocystis jiroveci pneumonia after bendamustine-based chemotherapy for refractory diffuse large B-cell lymphoma
-
Ha J, Jung Y, Jung Y, Lee S, Lee Y, Woo I
- KMID: 2172747
- Blood Res.
- 2016 Mar;51(1):61-63.
- doi: 10.5045/br.2016.51.1.61
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of an international scale method and a log reduction method for monitoring of early molecular response in chronic myeloid leukemia patients
-
Ahn S, Lim YA, Lee WG, Jeong SH, Park JS, Cho SR
- KMID: 2172746
- Blood Res.
- 2016 Mar;51(1):58-61.
- doi: 10.5045/br.2016.51.1.58
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma
-
Park JA, Shin HY
- KMID: 2172745
- Blood Res.
- 2016 Mar;51(1):50-57.
- doi: 10.5045/br.2016.51.1.50
BACKGROUND: Methotrexate (MTX), one of the main drugs used to treat osteosarcoma, is a representative folic acid antagonist. Polymorphisms of various enzymes involved in the metabolism of MTX could contribute... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature
-
Bommannan , Sachdeva M, Malhotra P, Kumar N, Sharma P, Naseem S, Ahluwalia , Das R, Varma N, Prakash G, Khadwal A, Srinivasan R, Varma S
- KMID: 2172741
- Blood Res.
- 2016 Mar;51(1):23-30.
- doi: 10.5045/br.2016.51.1.23
BACKGROUND: Plasma cell leukemia (PCL) is a rare and aggressive plasma cell neoplasm. In PCL, clonal plasma cells comprise ≥20% of the peripheral blood (PB) leukocytes and/or the absolute clonal... -
- CITED
-
- Close
- SHARE
-
- Close
- Humanizing NOD/SCID/IL-2Rγnull (NSG) mice using busulfan and retro-orbital injection of umbilical cord blood-derived CD34+ cells
-
Kang YK, Ko Y, Choi A, Choi HJ, Seo JH, Lee M, Lee JA
- KMID: 2172742
- Blood Res.
- 2016 Mar;51(1):31-36.
- doi: 10.5045/br.2016.51.1.31
BACKGROUND: Humanized mouse models are still under development, and various protocols exist to improve human cell engraftment and function. METHODS: Fourteen NOD/SCID/IL-2Rγnull (NSG) mice (4‒5 wk old) were conditioned with busulfan... -
- CITED
-
- Close
- SHARE
-
- Close
- Survey of experts on therapeutic policies and proposals for the optimal timing for allogeneic peripheral blood stem cell transplantation in transfusion-dependent patients with myelodysplastic syndrome-refractory anemia
-
Sohn SK, Moon JH, Lee YJ, Park SW, Kim JY
- KMID: 2172744
- Blood Res.
- 2016 Mar;51(1):44-49.
- doi: 10.5045/br.2016.51.1.44
BACKGROUND: Most hypomethylating agent (HMA) responders with myelodysplastic syndrome (MDS) eventually need allogeneic stem cell transplantation (SCT) because they often acquire resistance to HMAs within two years of treatment. Considering... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term course of anti-factor VIII antibody in patients with hemophilia A at a single center
-
Yoo KY, Joo SC, Choi YM
- KMID: 2172743
- Blood Res.
- 2016 Mar;51(1):37-43.
- doi: 10.5045/br.2016.51.1.37
BACKGROUND: Immune tolerance induction (ITI) can reduce inhibitors against factor VIII concentrates by 70-80%. In this study, we elucidated the characteristics of inhibitors and attempted to determine the proper indications... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescents
-
Im HJ, Koh KN, Seo JJ
- KMID: 2172739
- Blood Res.
- 2016 Mar;51(1):8-16.
- doi: 10.5045/br.2016.51.1.8
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for children and adolescents with various malignant and non-malignant diseases. While human leukocyte antigen (HLA)-identical sibling donor is the preferred... -
- CITED
-
- Close
- SHARE
-
- Close
- A scientific treatment approach for acute mast cell leukemia: using a strategy based on next-generation sequencing data
-
Youk J, Koh Y, Kim JW, Kim DY, Park H, Jung WJ, Ahn KS, Yun H, Park I, Sun CH, Lee S, Yoon SS
- KMID: 2172740
- Blood Res.
- 2016 Mar;51(1):17-22.
- doi: 10.5045/br.2016.51.1.17
BACKGROUND: Mast cell leukemia (MCL) is the most aggressive form of systemic mastocytosis disorders. Owing to its rarity, neither pathogenesis nor standard treatment is established for this orphan disease. Hence,... -
- CITED
-
- Close
- SHARE
-
- Close
